🇺🇸 FDA
Pipeline program

intraileal infusion

QLYY-CRC-2020-001

Unknown other completed

Quick answer

intraileal infusion for Incretins is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Incretins
Phase
Unknown
Modality
other
Status
completed

Clinical trials